A detailed history of Lgt Fund Management CO Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Lgt Fund Management CO Ltd. holds 1,403 shares of VRTX stock, worth $631,869. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,403
Previous 1,359 3.24%
Holding current value
$631,869
Previous $636,000 2.52%
% of portfolio
0.07%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$460.0 - $505.78 $20,240 - $22,254
44 Added 3.24%
1,403 $652,000
Q2 2024

Aug 07, 2024

BUY
$392.81 - $485.53 $533,828 - $659,835
1,359 New
1,359 $636,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Lgt Fund Management CO Ltd. Portfolio

Follow Lgt Fund Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Fund Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Lgt Fund Management CO Ltd. with notifications on news.